
Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study
Keywords: آسپارتات ترانس آمیناز یا AST ; AE; adverse event; AFP; alpha fetoprotein; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; OS; overall survival; PVTT;